Albemarle Corporation (ALB) is slated to release first-quarter 2025 results after the closing bell on April 30.The company missed the Zacks Consensus Estimate for earnings in each of the trailing four quarters. In this timeframe, it delivered a negative earnings surprise of 160.2%, on average. It posted a negative earnings surprise of 122.5% in the last reported quarter. ALB is likely to have benefited from its cost and productivity actions in the first quarter amid headwinds from softer lithium market pric ...

The upcoming report from Albemarle (ALB) is expected to reveal quarterly loss of $0.62 per share, indicating a decline of 338.5% compared to the year-ago period. Analysts forecast revenues of $1.17 billion, representing a decrease of 13.9% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 192.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company' ...

Albemarle (ALB) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 30. On the ...

The stock market’s sentiment gauge is no different from any other pendulum, which occasionally causes swings in either overly bullish or overly bearish sentiment.  As it turns out, President Trump's rollout of trade tariffs has caused a lot of negative talk about the broader S&P 500 index and its constituents. However, some names could be set to rebound quicker than the bears may think after uncertainties subside. Once the fog of tariff uncertainty lifts, high short-interest stocks could become prime candid ...

Albemarle (ALB) shares ended the last trading session 19.1% higher at $60.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 30.2% loss over the past four weeks.The rally in ALB was fueled by a broader rise in material stocks after President Trump paused reciprocal tariffs for most countries for 90 days.This specialty chemicals company is expected to post quarterly loss of $0.37 per share in its upcoming report, w ...

I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the ...

Company Performance - Albemarle's stock closed at $58.10, reflecting a -0.7% change from the previous day, underperforming the S&P 500's daily loss of 0.23% [1] - Over the past month, Albemarle's shares have decreased by 22.51%, significantly trailing the Basic Materials sector's loss of 8.32% and the S&P 500's loss of 12.13% [1] Upcoming Earnings - The upcoming earnings report for Albemarle is scheduled for April 30, 2025, with an expected EPS of -$0.37, indicating a 242.31% decline from the same quarter last year [2] - Revenue is forecasted to be $1.2 billion, representing an 11.86% decrease compared to the same quarter of the previous year [2] Full Year Estimates - For the full year, analysts expect earnings of -$0.05 per share and revenue of $5.02 billion, which would reflect a +97.86% change in earnings and a -6.69% change in revenue from the previous year [3] - Recent changes to analyst estimates suggest evolving short-term business trends, with positive revisions indicating a favorable business outlook [3] Zacks Rank and Industry Performance - Albemarle currently holds a Zacks Rank of 3 (Hold), with a consensus EPS projection that has decreased by 14.29% in the past 30 days [5] - The Chemical - Diversified industry, which includes Albemarle, has a Zacks Industry Rank of 214, placing it in the bottom 14% of over 250 industries [6]

Albemarle (ALB) closed at $79.49 in the latest trading session, marking a +1.26% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 1.08%. Elsewhere, the Dow saw an upswing of 0.92%, while the tech-heavy Nasdaq appreciated by 1.41%.Heading into today, shares of the specialty chemicals company had lost 6.08% over the past month, lagging the Basic Materials sector's loss of 1.64% and outpacing the S&P 500's loss of 8.26% in that time.Investors will be eagerly watching fo ...

It has been about a month since the last earnings report for Albemarle (ALB) . Shares have lost about 8.6% in that time frame, outperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Albemarle due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turns o ...

Core Viewpoint - The current market focus on the technology sector, particularly artificial intelligence, has led to undervaluation of other sectors, presenting opportunities for value investors [1][2]. Group 1: Cleveland-Cliffs Inc. (NYSE: CLF) - Institutional investors, such as Dimensional Fund Advisors, increased their holdings in Cleveland-Cliffs by 3.1%, raising their net position to $199.7 million, which represents 4.3% ownership [4]. - The anticipated rise in demand for domestic steel production due to recent trade tariffs is expected to drive higher prices for Cleveland-Cliffs [5]. - The current consensus price target for Cleveland-Cliffs is $16.7 per share, indicating a potential upside of up to 50% from current trading levels, as the stock is currently at 49% of its 52-week high [6]. - There has been an 8.2% decline in short interest for Cleveland-Cliffs over the past month, indicating a shift in sentiment among bearish traders [7]. Group 2: Albemarle Co. (NYSE: ALB) - Analysts forecast that Albemarle will achieve earnings per share (EPS) of $2.18 for Q2 2025, a significant improvement from a current net loss of $1.09 [8]. - The consensus price target for Albemarle is $109.7 per share, suggesting a potential rally of 35.4% from current levels, as the stock trades at 57% of its 52-week high [10][11]. - Albemarle offers a dividend payout of $1.62 per share, providing a yield of 2% for investors, which may attract more institutional investment [12]. Group 3: SentinelOne Inc. (NYSE: S) - Analysts from Oppenheimer initiated coverage on SentinelOne, which is currently trading at 75% of its 52-week high, indicating it is underperforming compared to other tech stocks [13]. - The Outperform rating from analysts suggests a valuation target of $32 per share for SentinelOne, representing a potential upside of 46.2% from current trading levels [14].